A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group.
about
Antiviral agents for treatment of herpes simplex virus infection in neonatesOral acyclovir suppression and neurodevelopment after neonatal herpesNeonatal conjunctivitis - a reviewHerpes simplex virus type 1 penetrates the basement membrane in human nasal respiratory mucosaPersistence of herpes simplex virus DNA in cerebrospinal fluid of neonates with herpes simplex virus encephalitis.Safety of High-dose Acyclovir in Infants With Suspected and Confirmed Neonatal Herpes Simplex Virus Infections.Molecular diagnosis of herpes simplex virus infections in the central nervous systemProspects for control of herpes simplex virus disease through immunization.Should acyclovir prophylaxis be used in late pregnancy in women with recurrent genital herpes infection? How to use a clinical decision analysisPotent in vivo antiviral activity of the herpes simplex virus primase-helicase inhibitor BAY 57-1293.Advances in the treatment of neonatal herpes simplex infections.Population pharmacokinetics of intravenous acyclovir in preterm and term infants.Hematogenous vertical transmission of herpes simplex virus type 1 in miceImpact of Herpes simplex virus load and red blood cells in cerebrospinal fluid upon herpes simplex meningo-encephalitis outcome.Herpes simplex virus infection in pregnancy.Herpes simplex virus infections of women and their offspring: implications for a developed society.Plasma and cerebrospinal fluid herpes simplex virus levels at diagnosis and outcome of neonatal infection.Preventing herpes simplex virus in the newborn.N-Methanocarbathymidine is more effective than acyclovir for treating neonatal herpes simplex virus infection in guinea pigsNeonatal herpes prevention: a minor public health problem in some communities.Estimating the costs and benefits of screening monogamous, heterosexual couples for unrecognised infection with herpes simplex virus type 2.Neonatal herpes simplex infection.Management of women with recurrent genital herpes in pregnancy in Australia.Relapse of neonatal herpes simplex virus infectionHerpes simplex virus-2 (HSV-2) type-specific antibody correlates of protection in infants exposed to HSV-2 at birth.Herpes simplex virus 2 infection rate and necessity of screening during pregnancy: a clinical and seroepidemiologic study.The use of antiviral drugs during the neonatal periodAntiviral therapy: current concepts and practicesAntiviral therapy for genital herpes infections in pregnancy.Diagnosis of herpes simplex virus infections of the CNS.Neonatal herpes simplex virus infections: where are we now?Main adult herpes virus infections of the CNS.Guidance on management of asymptomatic neonates born to women with active genital herpes lesions.Primary Maternal Herpes Simplex Virus-1 Gingivostomatitis During Pregnancy and Neonatal Herpes: Case Series and Literature Review.Treatment of herpes simplex virus infections in pediatric patients: current status and future needs.Novel approaches in fighting herpes simplex virus infectionsAntiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection.Vertical transmission of genital herpes: prevention and treatment options.Early-onset neonatal sepsis.Management of genital herpes simplex infection.
P2860
Q24239986-EF663400-EC44-41B5-A6F4-4EDB91EFF0D4Q24615077-D76F4585-0D23-44FE-9D67-EBBBAB6AFB54Q28255751-7C9AA2F0-A169-47D5-BB5C-58ADC2199A0CQ28742559-D721C93A-EE61-49E3-B702-471A731FD7EEQ33405731-568E7CF1-1BB3-4B27-B158-B62B0C1EAC94Q33437643-FCAE66F2-4C09-407F-99F9-A73CDCA751F3Q33655137-E12E937F-6387-46C2-B4AF-088BD968CAC5Q33866424-06E121C2-4044-495E-BDD6-2E28C8348E94Q33936817-2351BF46-095B-4F87-B35D-A44C1E3E4544Q34109321-451BE8BF-7019-454D-A087-00F37A7F0591Q34263652-7D586488-0A96-4E94-93BE-BC39875B69D2Q34392526-993938C9-4E3D-4C01-9F6C-207F953C7C1AQ34435095-B19A8314-03CE-46F2-9AE8-049C305A9426Q34514286-B52CCAB7-2992-428E-92A3-089D90F980B9Q35066818-296D4CB0-7D8B-4F11-8D96-5CAA2EC81E8FQ35114519-1C132F5E-D8FF-4B17-9DAF-40B0F3E52CDDQ35236237-C9A8470A-EC5D-4730-9795-F28B6FFEA360Q35283797-5F894137-07F5-4C1F-B343-77E74A887A06Q35449587-88229E52-A459-45FA-94D1-961064D8B16FQ35528611-089FDFF4-CCA8-4B30-8D1C-AD636E87CBCCQ35530369-5374894F-97D9-45F1-93F1-BAC9D3DDF40FQ35545367-BE942126-4E3F-4BB3-951B-59ECF42AC242Q35562424-4B1ADFFA-FC45-4F42-8D15-64C187124BFDQ35571733-7CAC924A-9C5E-42ED-84C9-1C414AAA066EQ35605299-A1E4E444-38BB-4C29-87A8-79424466087AQ35767424-1F0CA47F-7FCC-454B-9D12-89AD9CE8621DQ35789702-422C02AE-7D1A-4E0C-9A0B-A0B129CDC151Q36070394-C850B5FA-1FF1-485F-942E-F7D4E68FABA9Q36162365-EEFB9FB1-1FB4-4CA6-98A1-7F9179E8872CQ36192705-4B625C0A-4BB2-440F-8CC0-5B6633C39BA1Q36206687-DBA8B923-F3F0-4E0F-9489-C753B778B4B0Q36233543-5C672686-8DA6-4518-9E7B-319415D1D115Q36568824-2646C035-9632-4BAE-9B0B-DB117BDE34BDQ36613109-485FDF4F-56B0-4C8A-985D-2BA06EA40D49Q36938445-1439A82C-B1E6-4533-8304-FBE8DE334434Q37316071-0EBF7306-C766-4F42-8EDB-DED60007004AQ37357122-8A29898E-8EE4-4E15-ACE7-2732E21618C5Q37424183-0F824B33-0036-4924-B152-26FCE6BDE288Q37544901-BCC254B7-4EC1-4FE6-8803-2E8E946BD00FQ37545127-D65F31BB-4F6C-4899-8F11-E048864DB879
P2860
A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group.
description
1991 nî lūn-bûn
@nan
1991 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
A controlled trial comparing v ...... orative Antiviral Study Group.
@ast
A controlled trial comparing v ...... orative Antiviral Study Group.
@en
type
label
A controlled trial comparing v ...... orative Antiviral Study Group.
@ast
A controlled trial comparing v ...... orative Antiviral Study Group.
@en
prefLabel
A controlled trial comparing v ...... orative Antiviral Study Group.
@ast
A controlled trial comparing v ...... orative Antiviral Study Group.
@en
P2093
P1476
A controlled trial comparing v ...... orative Antiviral Study Group.
@en
P2093
Burchett S
P304
P356
10.1056/NEJM199102143240703
P407
P577
1991-02-01T00:00:00Z